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The Na,K-ATPase classically serves as an ion pump creating an electrochemical gradient
across the plasmamembrane that is essential for transepithelial transport, nutrient uptake
and membrane potential. In addition, Na,K-ATPase also functions as a receptor, a signal
transducer and a cell adhesion molecule. With such diverse roles, it is understandable
that the Na,K-ATPase subunits, the catalytic α-subunit, the β-subunit and the
FXYD proteins, are controlled extensively during development and to accommodate
physiological needs. The spatial and temporal expression of Na,K-ATPase is partially
regulated at the transcriptional level. Numerous transcription factors, hormones, growth
factors, lipids, and extracellular stimuli modulate the transcription of the Na,K-ATPase
subunits. Moreover, epigenetic mechanisms also contribute to the regulation of Na,K-
ATPase expression. With the ever growing knowledge about diseases associated
with the malfunction of Na,K-ATPase, this review aims at summarizing the best-
characterized transcription regulators that modulate Na,K-ATPase subunit levels. As
abnormal expression of Na,K-ATPase subunits has been observed in many carcinoma,
we will also discuss transcription factors that are associated with epithelial-mesenchymal
transition, a crucial step in the progression of many tumors to malignant disease.
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INTRODUCTION
Na,K-ATPase is an integral membrane protein that mainly functions as an ion pump, hydrolyzing
one molecule of ATP to pump three Na+ out of the cell in exchange for two K+ entering the cell
per pump cycle. This function is crucial to maintaining the ion gradient across the membrane
and is critical for the resting membrane potential, electrical activity of muscle and nerve, Na+-
coupled transport, and osmotic balance and cell volume regulation (Blanco et al., 1998; Kaplan,
2002). Besides being an ion pump, Na,K-ATPase acts as a signal transducer (Xie and Askari,
2002; Pierre and Xie, 2006; Rajasekaran and Rajasekaran, 2009; Reinhard et al., 2013). Both α-
and β-subunit associate with various signaling molecules, including Src, phosphoinositide 3-kinase
(PI3K), caveolin-1, protein phosphatase 2, and EGFR thereby activating a number of intracellular
Abbreviations: CRE, cAMP response element; EMT, epithelial-mesenchymal transition; FGFs, fibroblast growth factors; GR,
glucocorticoid receptor; GRE, glucocorticoid response element; HRE, hypoxia response element; MR, mineralocorticoid
receptor; MRE, mineralocorticoid response element; Na,K-ATPase, sodium,potassium-adenosine triphosphatase; NRF1,
nuclear respiratory factor 1; PGE1, prostaglandin E1; PGRE, prostaglandin response element; PR, progesterone receptor;
PRE, progesterone response element; SBD, Smad binding domain; Sp, specificity protein; SRE, serum response element; TGF-
β, transforming growth factor-β; TR, thyroid hormone receptor; TRE, thyroid hormone response element; ZEB1, zinc finger
E-box binding homeobox.
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signaling pathways, including MAPK and Akt signaling, to
modulate cell polarity, cell growth, cell motility and gene
expression (Haas et al., 2002; Barwe et al., 2005; Cai et al., 2008;
Kimura et al., 2011). Na,K-ATPase also functions as a receptor for
the cardiac glycoside ouabain, a specific inhibitor of the pump.
Studies with ouabain at concentrations that do not inhibit the
Na,K-ATPase pump function have been particularly useful in
elucidating the pump-independent signaling pathways associated
with Na,K-ATPase (Xie and Askari, 2002; Silva and Soares-da-
Silva, 2012; Reinhard et al., 2013). Na,K-ATPase also regulates the
formation and stabilization of intercellular junctions and the β1
and β2-subunits act as cell adhesion molecules (Gloor et al., 1990;
Rajasekaran et al., 2001a,b; Vagin et al., 2006, 2012).
Na,K-ATPase is an abundantly expressed protein and can
use up to about 2/3 of the energy expenditure of a cell
(Howarth et al., 2012) thus requiring tight regulation. Aberrant
expression and/or function of Na,K-ATPase has been associated
with many disorders, with cancer being one of the more
recent ones (Litan and Langhans, 2015). This review will
focus on the transcriptional regulation of Na,K-ATPase by
hormones, transcription factors, growth factors, extracellular
stimuli, and epigenetic modification in general; followed by the
role of transcription factors involved in epithelial-mesenchymal
transition (EMT) and carcinoma.
THE EXPRESSION PROFILE OF
Na,K-ATPase
Na,K-ATPase is a heteromeric transmembrane protein composed
of an essential α- and β-subunit (Lingrel and Kuntzweiler,
1994), and an optional third subunit belonging to the FXYD
proteins which are more tissue specific regulatory subunits of the
enzyme (Geering, 2006). The α-subunit is the catalytic subunit
responsible for transport activities of the enzyme. It contains
10 transmembrane segments; a large intracellular domain and
a simple extracellular domain. An ATP-binding site and a
phosphorylation site locate within the large cytoplasmic loops.
The extracellular domain and the transmembrane regions harbor
the binding sites for cardiac glycosides such as digoxin and
ouabain (Kaplan, 2002; Sandtner et al., 2011; Laursen et al., 2013).
The β-subunit is a highly glycosylated transmembrane protein,
which increases the translation efficiency and stability of the
α-subunit and targets the α-subunit to the plasma membrane
(Blanco et al., 1998; Rajasekaran et al., 2004; Benarroch, 2011). It
also modulates the affinity of Na+ and K+ to the enzyme (Blanco
et al., 1998) and functions as a cell adhesion molecule (Gloor
et al., 1990; Rajasekaran et al., 2001b; Barwe et al., 2005; Kitamura
et al., 2005; Shoshani et al., 2005; Vagin et al., 2006, 2012).
Unlike the α-subunit, the β-subunit spans the plasma membrane
only once and has a very short intracellular N-terminus and
a large extracellular C-terminal domain that contains several
N-glycosylation sites (Blanco et al., 1998; Benarroch, 2011). In
recent years, the FXYD family has been identified as another
subunit of Na,K-ATPase. They are a group of small, single-
span membrane proteins that are characterized by the FXYD
motif in the extracellular domain, two conserved glycine residues
within the membrane, and a serine residue at the membrane-
cytoplasm interface (Garty and Karlish, 2006; Geering, 2008).
FXYD proteins modify the affinity for Na+, K+, and ATP, pump
kinetics and transport properties and stabilize Na,K-ATPase
(Garty and Karlish, 2006; Geering, 2006, 2008; Mishra et al.,
2011).
The Na,K-ATPase subunits are highly conserved across
species and among isoforms. Four isoforms of α-subunit (α1–α4)
and three isoforms of β-subunit (β1–β3) have been identified
so far, which are encoded by different genes (Blanco, 2005). In
human, there is high identity in amino acid sequence among the
α-subunit isoforms with 87% identity between α2 and α1 and
88% between α3 and α1. α4 is a little more divergent, but still
sharing 79% identity with α1. The β-subunit isoforms are more
diverse. Compared to β1, β2 shows 39% identity and β3 is 36%.
Seven different FXYD proteins have been identified (FXYD1 to
FXYD7), which show 43 ∼ 51% identity in their amino acid
sequence.
The α- and β-subunits are expressed in a tissue specific
manner (Herrera et al., 1987; Orlowski and Lingrel, 1988;
Sweadner, 1989; Blanco et al., 1998; Benarroch, 2011). The α1-
subunit is present in most tissues and the highest expression is
found in kidney, brain and heart. Compared to the broad tissue
distribution of the α1-subunit, the expression of other α-subunit
isoforms is more restricted. The α2-subunit predominates in
skeletal muscle, brain and heart; the α3-subunit is abundant
in nervous tissue and heart. The α4-subunit was discovered
as a testis-specific subunit (Shamraj and Lingrel, 1994), but
now has also been found in adult human and mouse skeletal
muscle (Keryanov and Gardner, 2002). Within the nervous
system, the α-subunit isoforms are expressed in a cell type
specific manner. For example, the α1-subunit is expressed in
both neurons and glial cells, the α2-subunit is primarily found in
astrocytes and oligodendrocytes and the α3-subunit is abundant
in neurons (Benarroch, 2011). Like the α1-subunit, the β1-
subunit is ubiquitously expressed in almost all tissues with the
greatest levels in brain and kidney (Orlowski and Lingrel, 1988).
The β2-subunit is mainly found in nervous tissue, kidney and
heart (Avila et al., 1998), whereas the β3-subunit predominates
in kidney and adrenal gland but is also presents in brain,
lung and liver (Malik et al., 1998). The FXYD proteins show a
tissue-specific distribution as well. FXYD1 (phospholemman) is
expressed in heart and skeletal muscle; FXYD2 (γ-subunit) in
kidney; FXYD3 (MAT-8) in stomach and colon; FXYD4 (CHIF)
in kidney and colon; FXYD5 (dysadherin) in intestine, lung and
kidney; FXYD6 and FXYD7 in brain (Garty and Karlish, 2006;
Geering, 2006). In addition, the expression levels of α- and β-
subunit change during development. For example, in brain, all
three α-subunit isoforms increase in abundance from fetus to
adult (Orlowski and Lingrel, 1988). However, the α1-subunit is
more abundant in fetal kidney and heart than in adult tissues
(Herrera et al., 1987). In rat heart, the α3-subunit decreases
sharply after birth and is replaced by α2-subunit in adults (Zahler
et al., 1996). The β1-subunit increases in the early stage of
embryonic development, but decreases to the basal level during
embryo implantation (Deng et al., 2013). With these diverse
tissue distributions of Na,K-ATPase subunit isoforms, multiple
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Na,K-ATPase isozymes can form, rendering cells able to respond
more precisely to extracellular stimuli. For instance, while in
kidney α1β1 is the major αβ complex, all combinations of αβ
complexes have been found in heart and brain (Mobasheri et al.,
2000).
The spatial and temporal control of Na,K-ATPase expression
occurs at the transcriptional, post-transcriptional, translational
and post-translational level. Here, we will review findings on the
transcriptional regulation of Na,K-ATPase over the past decades
(Table 1). Extracellular stimuli, such as growth factors play a key
role in the regulation of Na,K-ATPase by activating intracellular
signaling pathways including protein kinase A (PKA), protein
kinase C (PKC), and other Ca2+-regulated signaling pathways.
Numerous DNA-binding-site-specific transcription factors have
been reported to be involved in the regulation of Na,K-ATPase
expression, including hormone receptors, Snail1, specificity
protein (Sp) and Zinc finger E-box-binding homeobox 1 (ZEB1).
Recently, it has been shown that hypermethylation in promoter
regions of human ATP1B1 gene is associated with reduced
expression of β1-subunit (Selvakumar et al., 2014), indicating
that epigenetic modification might be another mechanism of
transcriptional regulation of Na,K-ATPase subunits.
PROMOTER ANALYSIS OF Na,K-ATPase α-
AND β-SUBUNITS
Transcription factors activate or repress Na,K-ATPase expression
by binding to specific DNA elements on the promoter regions.
There are numerous sequence-specific elements on the promoter
regions of the various Na,K-ATPase subunits, of which β1 has
been extensively studied (Figure 1).
α1-subunit
The α1-subunit is encoded by the gene ATP1A1. The
ATP1A1 promoter has very high GC content, which is a
common characteristic of all housekeeping genes. It contains
a potential TATA box (−27 bp; Shull et al., 1990), two
mineralocorticoid/glucocorticoid response element (MRE/GRE)
sites (−598 to−574 bp and−252 bp; Kolla et al., 1999); potential
binding sites for AP-1(−507 and −453 bp), AP-2 (−568 and
−380 bp), AP-3 (−286 bp), and several CTF/NF-1 and potential
Sp1 binding sites (Shull et al., 1990). The nucleotide sequence
from around−100 bp to the transcription initiation site is highly
conserved among the human and rat Atp1a1 genes (Kobayashi
et al., 1997). An asymmetrical ATF/CRE site (−77 to −64 bp) is
found in the rat Atp1a1 promoter (Kobayashi and Kawakami,
1995). In addition, the rat Atp1a1 promoter contains a Sp1
consensus sequence (−56 to −51 bp) and a Sp1 binding site
(−120 to−106 bp; Suzuki-Yagawa et al., 1992).
α2-subunit
The α2-subunit is encoded by the gene ATP1A2. The promoter
region of human ATP1A2 contains a potential TATA box, two
potential Sp1 recognition sites, numerous potential AP-1, AP-2,
and NF-1 binding sites, and several sequences that are similar
to the glucocorticoid receptor binding site (Shull et al., 1989;
Malyshev et al., 1991). The major positive regulatory elements
are located at the position from −175 to −108 bp on the
rat Atp1a2 gene, harboring two E boxes (−144 to −139 bp
and −135 to −130 bp), a Spl binding consensus sequence (−123
to−118 bp) and a Sp1 binding site (−114 to−109 bp; Ikeda et al.,
1993).
α3-subunit
The α3-subunit is encoded by the gene ATP1A3. The human
ATP1A3 promoter has high GC content, but no conventional
TATA box (Malyshev et al., 1991). Sequence analysis reveals
several potential Sp-1 binding sites and AP-1 sites, two AP-2 sites,
two AP-4 sites, three GRE elements, two CACCC sequences, a
NF-1 binding site, a couple of TRE elements (Pathak et al., 1990),
and the binding sites for CREB/ATF and NF-Y/C-EBP (Benfante
et al., 2005). These sites are well conserved between the human
and rat Atp1a3 gene (Pathak et al., 1990). It was subsequently
shown that two Sp1 binding sites (−110 to −100 bp; −59
to −47 bp), a CCAAT box (−64 to −61 bp) and a half CRE-
like site (−87 to −83 bp) are functional. Mutations in the Sp1
binding site (−110 to −100 bp) or the CCAAT box significantly
reduced the ATP1A3 promoter activity and these two sites
worked synergistically in inducing ATP1A3 promoter activity.
The CRE-like element itself did not affect ATP1A3 promoter
activity, but cooperated with the upstream Sp1 site (Benfante
et al., 2005). Three TRE elements (−636 to −457 bp; −218
to −106 bp; and −106 to −6 bp) showed strong and specific
interaction with thyroid hormone receptor (TR) and modulated
ATP1A3 promoter activity (Bajpai et al., 2001). In addition, the
region from −210 bp to the transcription initiation site was
sufficient to direct brain-specific expression of the rat α3-subunit
(Pathak et al., 1994).
α4-subunit
The α4-subunit is encoded by the gene ATP1A4. In silicon
sequence analysis of putative promoter regions of human and
mouse ATP1A4 showed that they do not contain a TATA-
box sequence, but have potential binding sites for transcription
factors AP-1, AP-4, GATA3, NF-Y, MYOD, NF-1, NFAT
(Keryanov and Gardner, 2002) and two consensus CRE sites
(Rodova et al., 2006). However, ATP1A4 does not have any Sp1
binding site that is common on the promoter regions of other
subunits (Keryanov and Gardner, 2002).
β1-subunit
The β1-subunit is encoded by the gene ATP1B1. It contains
three potential MRE/GRE half sites (−1048 to −1027 bp; −650
to −630 bp; −276 to −271 bp; Derfoul et al., 1998), four E-boxes
(−752 to −747 bp; −708 to −703 bp; −654 to −649 bp; −509
to −504 bp), a non-canonical E-box (−71 to −66 bp), a NF-
1 binding site (−657 to −653 bp; Espineda et al., 2004), three
prostaglandin response elements (PGRE:−445 to−438 bp;−226
to −216 bp; −100 to −92 bp; Matlhagela et al., 2005; Matlhagela
and Taub, 2006), a putative hypoxia response element (HRE:
−750 to −746 bp; Mony et al., 2013), a Smad binding domain
(SBD: −728 and −721 bp; Mony et al., 2013), three thyroid
hormone response elements (TRE; Feng et al., 1993), three
progesterone element (PRE) half sites (Cochrane et al., 2012) and
several Sp1 binding sites (Matlhagela et al., 2005; Matlhagela and
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TABLE 1 | Examples of factors that transcriptionally regulate Na,K-ATPase.
Regulator The roles in regulating Na, K-ATPase transcription References
11-Dehydrocorticosterone Increased α1 and β1 mRNA in vascular smooth muscle cells Muto et al., 1998a
8-Bromo-cAMP Increased α1 and β1 mRNA in a rat kidney epithelial cell line Whorwood and Stewart, 1995
Aldosterone Increased α1 and β1 mRNA in A6 kidney cells from Xenopus laevis Verrey et al., 1987, 1988, 1989
Increased α1 and β1 mRNA in adult and neonatal rat cardiocytes Ikeda et al., 1991
Increased α1 and β1 mRNA in vascular smooth muscle cells Oguchi et al., 1993
Increased α3 mRNA in rat hippocampus Farman et al., 1994
Increased α1 and β1 mRNA in rat vascular smooth muscle cells Muto et al., 1996
Increased α1 in rat cortical collecting duct Tsuchiya et al., 1996
Increased α3 and β1 in hippocampus, gyrus dentatus and periventricular gray
substance
Grillo et al., 1997
Increased α1 mRNA in the renal cortex Seok et al., 1999
Increased β1 mRNA in alveolar type 2 (AT2) cells Olivera et al., 2000
Increased α1, but not β1 mRNA in cortical collecting duct cells Blot-Chabaud et al., 2001
Increased α2and β1 mRNA in human skeletal muscle Phakdeekitcharoen et al., 2011
Ammonia Increased α2, but not α1 mRNA, decreased α3 mRNA Xue et al., 2010
Angiotensin II Increased α1 and β1 mRNA Isenovic et al., 2004
Betamethasone Increased α1 and β mRNA level in 10-day-old rats, but not in adult rats Celsi et al., 1991
Increased α1, α2, β1, but not α3 mRNA in infant rat heart Wang and Celsi, 1993
Increased α1 and β1 mRNA in infant rat kidney Wang et al., 1994
C peptide Increased α1 mRNA in human renal tubular cells Galuska et al., 2011
Caffeine Decreased α1 and β1 mRNA in rat kidney Lee et al., 2002
Cholera toxin Increased β1, but not α1 mRNA in a rat kidney epithelial cell line Whorwood and Stewart, 1995
Corticosterone Increased α1 and β1 mRNA in vascular smooth muscle cells Muto et al., 1998a
Cyclic stretch Increased α1and α2 mRNA in aortic smooth muscle cells Sevieux et al., 2001
db-cAMP Increased α1, but not β1 mRNA Dagenais et al., 2001
Dexamethasone Increased α2, but not α1, α3, and β mRNA in cultured neonatal rat cardiac
myocytes
Orlowski and Lingrel, 1990
Increased α1 and β1 mRNA in a rat liver cell line Bhutada et al., 1991
Increased α1 and β1 mRNA in fetal rat lung epithelial cell line Chalaka et al., 1999
Increased α3 and β1 mRNA in rat spinal cords González et al., 1994, 1996
Increased α1 and β1 mRNA in rat vascular smooth muscle cells Muto et al., 1996
Increase β1, but not α1 mRNA in alveolar epithelial type II cells Barquin et al., 1997
Increased β1, but not α1 mRNA in fetal lungs Ingbar et al., 1997
Increased α1 and β1 mRNA in a fetal rat lung epithelial cell line Chalaka et al., 1999
Increased β1, but not α1 mRNA in rat alveolar epithelial cells Dagenais et al., 2001; Hao et al., 2003a,b
Decreased α1 mRNA in rat capsule-epithelium of lenses Xie and Askari, 2002
DNA methylation Decreased α3, β1 and FXYD1 mRNA Henriksen et al., 2013; Selvakumar et al., 2014
Dopamine Increased β1 mRNA in rat alveolar epithelial cells Guerrero et al., 2001
EGF Increased α1and β1 mRNA in alveolar epithelial cells Danto et al., 1998
Increased α2 but not α1 mRNA in primary cultures of mouse astrocytes Xue et al., 2010
Elevated Ca2+ Increased α1 and β1 mRNA in rat kidney Rayson, 1991
Elevated intracellular Na+ Increased α1 and β1 mRNA in rat kidney epithelial cells Muto et al., 2000
FGF Increased α1 and β1 mRNA in vascular smooth muscle cells Nemoto et al., 1997
Forskolin Increased α1 and β1mRNA in a rat kidney epithelial cell line Whorwood and Stewart, 1995
Glucose Increases α1 and β1 mRNA Muto et al., 1998a
Glycyrrhetinic acid Decreased α1 and β1 mRNA in rat kidney epithelial cells Whorwood and Stewart, 1995
High-fat diet Increased α1 mRNA in nuclear extracts from gastrocnemius muscle Galuska et al., 2009
Hyperoxia Selectively increased β1 mRNA in MDCK cells Wendt et al., 1998
Hypoxia Down-regulated the expression of Na,K-ATPase in alveolar cells, renal proximal
tubule cells and lung cancers
Planes et al., 1997; Adachi et al., 2004; Yu and
Hales, 2011
(Continued)
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TABLE 1 | Continued
Regulator The roles in regulating Na, K-ATPase transcription References
IL-2 Increased α1 and β1 mRNA in human blood lymphocytes Karitskaya et al., 2010
Insulin Increased α2, not α1 mRNA, decreased β1 mRNA in 3T3-L1 cells Russo and Sweadner, 1993
Increased α2, not α1 mRNA in VSMC cells Tirupattur et al., 1993
Ischemia and reflow Decreased α1 and β mRNA level in rat kidney Van Why et al., 1994
KCl Increased α1, α3, and β1 mRNA in neurons Johar et al., 2012, 2014
KGF Increased α1, but not β1 mRNA in alveolar type II cells Borok et al., 1998
Low K+ Increased α1 and β1 mRNA in cultured renal proximal tubule cells Tang and McDonough, 1992
Increased α1 and β1 mRNA in rat cardiac myocytes Qin et al., 1994; Zhuang et al., 2000; Wang
et al., 2007b
Mannitol Increased α1and β1 mRNA Muto et al., 1998b
Manganese Decreased α3 mRNA in mice Wang et al., 2013
Nitric oxide Decreased α1 mRNA in medullary thick ascending limb of Henle (MTAL) cell lines Kone and Higham, 1999
NRF1 Increased β1 but decreased α1 mRNA Johar et al., 2012
Ouabain Increased α1 and β1 mRNAs in cultured rat astrocytes Hosoi et al., 1997
Increased α1 and β1 mRNA in rat kidney epithelial cells Muto et al., 2000
Regulated α3 and β1 mRNA in cultured neonatal rat cardiac myocytes Kometiani et al., 2000
Pertussis toxin Increased α1 and β1 mRNA in a rat kidney epithelial cell line Whorwood and Stewart, 1995
PHA Increased α1 and β1 mRNA in human blood lymphocytes Karitskaya et al., 2010
Progesterone Increased β1 mRNA Cochrane et al., 2012
Increased β1 mRNA in mouse uterus Deng et al., 2013
Prostaglandin E1 Increased α and β mRNA in MDCK cells Taub et al., 1992, 2004; Matlhagela and Taub,
2006
Increased α and β mRNA in rabbit renal proximal tubule cells Herman et al., 2010
Prostaglandin E2 Increased ATP1B1 promoter activity in rabbit renal proximal tubule cells Herman et al., 2010
Serum Increased α1 and β1 mRNA in a rat liver cell line, Clone 9 Kirtane et al., 1994
Increased α1 and β1 mRNA in vascular smooth muscle cells Nemoto et al., 1997
Snail1 Selectively repressed β1, but not α1 mRNA in MCF7 and MDCK cells Espineda et al., 2004
Sp (Sp1, Sp3, Sp4) Increased α1, α3, and β1 mRNA in murine neurons Johar et al., 2014
T3 Increased α and β mRNA in rat kidney cortex Gick and Ismail-Beigi, 1990
Increased α, but not β mRNA in rat liver Gick and Ismail-Beigi, 1990
Increased α and β mRNA in rat kidney McDonough et al., 1988
Increased α2, α3, and β, but not α1 mRNAs in neonatal rat cardiac myocytes Orlowski and Lingrel, 1990
Increased α1 and β mRNA in a rat liver cell line Clone 9 Gick and Ismail-Beigi, 1990
Increased α1, α3, and β1 mRNA in neonatal rat myocardium Melikian and Ismail-Beigi, 1991
Increased α1, α2, and β1 mRNA in cardiac myocytes Hensley et al., 1992
Increased α1, α2, α3, and β1 mRNA in cultured neonatal rat cardiocytes Kamitani et al., 1992
Increased α2 and β2 mRNA in skeletal muscle Azuma et al., 1993
Increased α1 and β1 mRNA in cultured rat mesangial cells Ohara et al., 1993
Increased α1 and β1 mRNA in in rat jejunum and Caco-2 cells Giannella et al., 1993
Increased α2 mRNA in neonatal rat cardiac myocytes Huang et al., 1994
Increased α and β mRNA in rabbit renal proximal tubule cells Lin and Tang, 1997
Increased α1, α2, and α3 mRNA in rat brain Bajpai and Chaudhury, 1999
Increased α2 and β1 mRNA in rat heart Shao et al., 2000
Increased α2 and β1 mRNA in human skeletal muscles Phakdeekitcharoen et al., 2007
T4 Increased α1, α2, and β1 mRNA in rat heart Shao et al., 2000
Tetrodotoxin Decreased α1, α3, and β1 mRNA in murine neurons Johar et al., 2012, 2014
TGF-β1 Decreased β1, α1, α2, and α3 mRNA in young FRTL-5 cells Pekary et al., 1997
TGF-β2 Selectively decreased β1 mRNA in ARPE-19 cell Mony et al., 2013
Uremia Decreased α1, but increased α2 in rat skeletal muscle Bonilla et al., 1991
Vasopressin Increased α1, but not β1 mRNA in cortical collecting duct cells Blot-Chabaud et al., 2001
Veratridine (a Na+ channel
activator)
Increased α1 and β1 mRNA in rat vascular smooth muscle cells Yamamoto et al., 1994
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FIGURE 1 | Regulatory elements in the promoter regions of human Na,K-ATPase subunits. The promoter regions of human Na,K-ATPase are shown in the
direction from 5′ to 3′. The colored boxes indicate potential transcription factor binding sites. The colored ovals represent experimentally verified transcription factor
binding sites.
Taub, 2006). Furthermore, the mouse Atp1b1 promoter region
also contains a Cebpb binding site (Deng et al., 2013). The 5′
flanking region of rat Atp1b1 shows 68% homology with human
ATP1B1. It contains a consensus TATA box sequence (−31 bp),
two CAAT boxes, four GC boxes, five half-site TREs, several
GRE and calcium and serum response elements (Liu and Gick,
1992).
β2-subunit
The β2-subunit is encoded by the gene ATP1B2. The region
from −280 bp to the transcriptional initiation site on the
promoter of ATP1B2 gene is highly conserved between rat,
mouse and human. The human ATP1B2 promoter contains a
consensus TATA sequence at position −94 bp and a Sp1 binding
site at position −120 bp (Avila et al., 1998). The mouse Atp1b2
promoter has a TATA-like sequence (−23 to −28 bp), a putative
CAAT box (−137 to −142 bp), and a GC box (−144 to −149 bp;
Shyjan et al., 1991). Sequence analysis revealed a potential TATA
box (−29 bp); two Sp1 binding sites (−55 and −147 bp) and
a serum response element (SRE: −263 bp) on the rat Atp1b2
promoter region (Kawakami et al., 1990). In addition, an AMOG
regulatory element (AMRE: GAGGCGGGG at position −87
to −79 bp) and a functional Sp1 binding site (−147 to −142 bp)
were found in rat Atp1b2 promoter regions (Kawakami et al.,
1992, 1993).
β3-subunit
The β3-subunit is encoded by the gene ATP1B3. The human
ATP1B3 promoter contains a TATA-like sequence (−413
to −408 bp) and two Sp1-like elements (−323 to −315 bp
and −312 to −304 bp). Moreover, the human ATP1B3 also has
four identical 32-nucleotide-long repeats from position −760
to−633 bp. The sequence from−1 to−328 bp on the 5′ flanking
region of human and mouse Atp1b3 shows high homology.
The mouse Atp1b3 promoter has one Sp1-like sequence (−319
to −310 bp), but does not have any TATA-like sequence. No
CAAT or GC boxes are present at the promoter region of human
or mouse Atp1b3 (Malik et al., 1998).
TRANSCRIPTIONAL REGULATION OF
Na,K-ATPase BY HORMONES AND
NUCLEAR RECEPTORS
Hormones are major regulators of Na,K-ATPase expression.
Mineralocorticoids (Verrey et al., 1987, 1988, 1989; Ikeda et al.,
1991; Oguchi et al., 1993; Farman et al., 1994; Muto et al., 1996;
Tsuchiya et al., 1996; Grillo et al., 1997; Seok et al., 1999; Olivera
et al., 2000; Blot-Chabaud et al., 2001; Phakdeekitcharoen et al.,
2011), glucocorticoids (Orlowski and Lingrel, 1990; Bhutada
et al., 1991; Celsi et al., 1991; González et al., 1994, 1996;
Muto et al., 1996; Barquin et al., 1997; Ingbar et al., 1997;
Chalaka et al., 1999; Dagenais et al., 2001; Hao et al., 2003a,b),
thyroid hormone (McDonough et al., 1988; Gick and Ismail-
Beigi, 1990; Orlowski and Lingrel, 1990; Melikian and Ismail-
Beigi, 1991; Hensley et al., 1992; Kamitani et al., 1992; Azuma
et al., 1993; Giannella et al., 1993; Ohara et al., 1993; Huang
et al., 1994; Lin and Tang, 1997; Bajpai and Chaudhury, 1999;
Shao et al., 2000; Phakdeekitcharoen et al., 2007), insulin (Russo
and Sweadner, 1993; Tirupattur et al., 1993; Sweeney and
Klip, 1998), progesterone (Cochrane et al., 2012; Deng et al.,
2013), androgen (Blok et al., 1999), and vitamin D3 (Billecocq
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et al., 1997) have been reported to activate or repress Na,K-
ATPase transcription. These hormones bind to and activate their
receptors, which belong to the family of nuclear receptors with
C4 zinc-fingers that then translocate into the nucleus to bind
to the promoter regions of the target genes to regulate gene
expression.
Mineralocorticoid Receptor (MR) and
Glucocorticoid Receptor (GR)
MR and GR are members of the nuclear receptor family.
They have three major functional domains: a N-terminal
regulatory domain (NTD); a DNA-binding domain (DBD) and
a ligand-binding domain (LBD; Kumar and Thompson, 2005).
The MR is highly homologous to the GR in the DBD and
LBD but not in the NTD (Kolla et al., 1999) and while
mineralocorticoids only activate the MR, glucocorticoids activate
both GR and MR. The activated MR and GR translocate into
the nucleus and bind to a specific palindromic DNA sequence
known as glucocorticoid/mineralocorticoid response element
(GRE/MRE) located in the promoter regions of target genes,
thus modulating gene transcription. The GRE is composed
of imperfect inverted hexanucleotide repeats separated by
three nucleotides (GGTACA NNN TGTTCT; Nordeen et al.,
1990).
Glucocorticoids regulate the transcription of Na,K-ATPase
in a variety of tissues including lung, kidney, liver, heart,
spinal cord, cardiac muscle and smooth muscle (Orlowski
and Lingrel, 1990; Bhutada et al., 1991; Celsi et al., 1991;
Wang and Celsi, 1993; González et al., 1994, 1996; Wang
et al., 1994; Muto et al., 1996; Barquin et al., 1997; Ingbar
et al., 1997; Chalaka et al., 1999; Dagenais et al., 2001; Hao
et al., 2003b). This regulation is specific to the cell type
and the developmental stage. For example, dexamethasone, a
synthetic potent glucocorticoid, increased the mRNA levels of
α1- and β1-subunit in a rat liver cell line and in a fetal rat
lung epithelial cell line (Bhutada et al., 1991; Chalaka et al.,
1999). However, in cultured neonatal rat cardiac myocytes,
dexamethasone only induced α2-subunit mRNA, and α1-, α3-,
and β-subunit transcripts remained unchanged (Orlowski and
Lingrel, 1990). Injection of betamethasone, another synthetic
analog of glucocorticoid, increased α1- and β-subunit mRNA
abundance in 10-day-old rats, but not in adult rats (Celsi et al.,
1991).
Mineralocorticoids, like aldosterone, also regulate the mRNA
levels of Na,K-ATPase in diverse tissues such as kidney, heart,
brain, vascular smooth muscle and skeletal muscle (Verrey
et al., 1987, 1988, 1989; Ikeda et al., 1991; Oguchi et al.,
1993; Farman et al., 1994; Tsuchiya et al., 1996; Grillo et al.,
1997; Seok et al., 1999; Olivera et al., 2000; Blot-Chabaud
et al., 2001; Phakdeekitcharoen et al., 2011). Aldosterone
increased both α1- and β1-subunit transcripts in kidney, heart
and vascular muscles and this up-regulation of β1-subunit
was much stronger than that of α1-subunit (Verrey et al.,
1987, 1988, 1989; Ikeda et al., 1991; Oguchi et al., 1993).
Aldosterone also increased α2- and β1-subunit mRNA in human
skeletal muscle (Phakdeekitcharoen et al., 2011). In addition,
aldosterone selectively up-regulated α3- and β1-subunit mRNA
in some brain regions, such as hippocampus, gyrus dentatus
and periventricular gray substance (Farman et al., 1994; Grillo
et al., 1997). The transcriptional regulation of α1- and β1-
subunit by aldosterone was mediated mostly by MR (Muto
et al., 1996; Kolla et al., 1999), whereas dexamethasone-mediated
induction of β1-subunit mRNA occurred through GR (Muto
et al., 1996). Inhibiting GR and MR activities by their specific
antagonists also reduced α1- and β1-subunit levels (Whorwood
et al., 1994; Hao et al., 2003b). In monkey kidney CV-1
cells, which have no detectable MR and GR, activation of
exogenous MR or GR alone by aldosterone or triamcinolone
acetonide increased β1-subunit gene promoter activity. However,
activation of both receptors inhibited transcription from the β1-
subunit gene promoter (Derfoul et al., 1998) and the N-terminal
region of MR mediated this inhibitory effect (Derfoul et al.,
2000).
The promoter region of the ATP1B1 gene contains
three potential MRE/GREs at nucleotide position −1048
to −1027 bp; −650 to −630 bp and −276 to −271 bp. The first
two contain two half-binding sites separated by 10 and 9 base
pairs, respectively, whereas the last one consists of a single
half-site. Although all three MRE/GREs were involved in the
induction of ATP1B1 promoter activity by corticoids, the one
at position −650 to −630 bp was the strongest (Derfoul et al.,
1998). Both MR and GR bound to the GRE/MRE (−650 to
−630 bp) and activated the transcription from a heterologous
neutral promoter in response to corticoids (Derfoul et al.,
1998; Hao et al., 2003b). A similar element was found in the
human ATP1A1 promoter region at position −598 to −574 bp
in which two half sites are separated by 12 base pairs. This
MRE/GRE bound both MR and GR and activated a heterologous
neutral promoter activity (Kolla et al., 1999). In addition, a
GRE (+434 to +448 bp) in the coding region of the rat Atp1b1
gene has been reported in a rat lung epithelial cell line. This
element acted as an enhancer and increased the transcription
from a heterologous promoter by dexamethasone (Hao et al.,
2003a).
Progesterone Receptor
Progesterone receptor (PR) also belongs to the nuclear receptor
family. PR’s sequence and architecture is very similar to MR
and GR (Leo et al., 2004). Like MR and GR, PR is activated by
its ligand progesterone and then translocates into the nucleus,
forms a homodimer and then binds to specific progesterone
response elements (PREs) within the promoter of target genes
to modulate transcription (Leonhardt et al., 2003). Progesterone
increased the mRNA and protein levels of β1-subunit (Cochrane
et al., 2012; Deng et al., 2013), and this up-regulation was
enhanced by estradiol-17β (Deng et al., 2013). RU486, a PR
antagonist, completely blocked the increase in β1-subunit mRNA
by progesterone (Deng et al., 2013). In addition, human β1-
subunit was up-regulated by both PR-A and PR-B, two different
PR isoforms (Richer et al., 2002). Moreover, PR bound to three
PRE half sites on the ATP1B1 promoter; Progestin, a synthetic
progestogen with similar effect to progesterone, induced ATP1B1
promoter activity, an induction that was suppressed by RU486
(Cochrane et al., 2012).
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Thyroid Hormone Receptor
Thyroid hormone receptor (TR) is a member of the nuclear
receptor superfamily and is activated by thyroid hormone,
triiodothyronine (T3) and its prohormone, thyroxine (T4).
Although TR alone can bind as monomer or homodimer to
specific DNA sequences in the gene promoter regions known
as thyroid hormone response elements (TREs), it preferentially
forms heterodimers with retinoid X receptor (RXR) and then
binds to TREs, thus enhancing or inhibiting the expression of
genes that are involved in development, homeostasis, cellular
proliferation and differentiation (Wu and Koenig, 2000). T3
has been shown to regulate the abundance of Na,K-ATPase
mRNA and protein in heart, kidney, liver, intestines, brain, and
skeletal muscle among others (McDonough et al., 1988; Gick
and Ismail-Beigi, 1990; Orlowski and Lingrel, 1990; Melikian
and Ismail-Beigi, 1991; Hensley et al., 1992; Kamitani et al.,
1992; Azuma et al., 1993; Giannella et al., 1993; Ohara et al.,
1993; Huang et al., 1994; Lin and Tang, 1997; Bajpai and
Chaudhury, 1999; Shao et al., 2000; Phakdeekitcharoen et al.,
2007). In general, T3 up-regulated the transcription of Na,K-
ATPase subunits. For example, T3 increased the mRNA levels of
α1-, α2-, α3-, and β1-subunit in cultured neonatal rat cardiocytes
(Kamitani et al., 1992) and α2-, β1-, and β2-subunit in skeletal
muscle (Azuma et al., 1993; Phakdeekitcharoen et al., 2007).
In hypothyroid rat brain, the mRNA level of α1-, α2-, and
α3-subunit was reduced during the first 3 weeks of brain
development (Chaudhury et al., 1996). The transcription of these
mRNAs was decreased in nuclei from hypothyroid cerebra and
pretreatment with T3 increased the rates of transcription (Bajpai
and Chaudhury, 1999). The promoter regions of Atp1a1, Atp1a2,
Atp1a3, and ATP1B1 genes have TRE sequences (Kamitani
et al., 1992; Feng et al., 1993; Giannella et al., 1993). In
addition, two negative thyroid receptor elements (−116 and
−6 bp and −6 and +80 bp) were found in rat Atp1a3 promoter.
The TR/RXR complex bound to these elements and inhibited
T3-mediated gene expression in neonatal rat cardiac myocytes,
which only occured with prolonged incubation with T3 (He et al.,
1996).
Insulin
Insulin is an important regulator of Na,K-ATPase. It binds to
insulin receptor and activates various cellular signaling pathways,
thus regulating cell functions. Insulin modulates Na,K-ATPase
activity by increasing Na+ influx; increasing the affinity of
Na,K-ATPase for intracellular Na+; altering phosphorylation
status of Na,K-ATPase and facilitating the translocation of
intracellular Na,K-ATPase to the plasma membrane. In addition,
insulin also regulates the transcription, translation and stability
of Na,K-ATPase (Ewart and Klip, 1995; Lavoie et al., 1996;
Sweeney and Klip, 1998; Therien and Blostein, 2000; Clausen,
2003). The transcriptional regulation of Na,K-ATPase by insulin
occurs in an isoform specific manner. For example, insulin
selectively increased α2, but not α1 mRNA level in vascular
smooth muscle cells (VSMC) and 3T3-L1 cells (Russo and
Sweadner, 1993; Tirupattur et al., 1993; Sweeney and Klip, 1998).





Specificity protein (Sp) is a small family of zinc-finger
transcription factors with four members: Sp1, Sp2, Sp3, and
Sp4. Sp1, Sp2, and Sp3 are ubiquitously expressed, while
Sp4 is expressed mainly in neurons and testes. The Sp
family members contain three zinc fingers close to the C-
terminus, which is DBD, and preferentially bind to the GC
box [(G/T)(G/A)GGC(G/T)(G/A)(G/A)(G/T)] on the promoter
regions of target genes to enhance gene expression. Sp1, Sp3,
and Sp4 have a highly conserved DBDs and they recognize
the same consensus GC rich element with identical affinities.
However, Sp2, in which the important histidine residue within
the first zinc finger is replaced by a leucine residue, does not
bind to the GC box but instead binds to a GT rich element
(Suske, 1999). Potential Sp1 binding sites were found on the
promoter regions of almost all Na,K-ATPase subunits, including
Atp1a1, Atp1a2, Atp1a3, Atp1b1, and Atp1b2 (Shull et al., 1989,
1990; Kawakami et al., 1990; Yagawa et al., 1990; Malyshev
et al., 1991; Suzuki-Yagawa et al., 1992; Ikeda et al., 1993; Yu
et al., 1996; Avila et al., 1998; Benfante et al., 2005). It has been
shown that Sp1 and Sp3 bind to GC boxes on the promoter
regions of rat Atp1a1 (Kobayashi et al., 1997) and Atp1b1
(Murakami et al., 1997). Mutations in the GC box sequences
decreased basal Atp1b1 transcription in neonatal rat cardiac
myocytes (Zhuang et al., 2000). Sp1, Sp3 and Sp4 also bind to
two Sp1 binding sites (−110 to −100 bp; −59 to −47 bp) on
human ATP1A3 promoter. Mutations in Sp1 binding site (−110
to−100 bp) significantly reduced the promoter activity (Benfante
et al., 2005). Recently, Sp1, Sp3, and Sp4 had been shown
to increase α1-, α3-, and β1-subunit transcription in murine
neurons by binding to their promoter regions (Johar et al.,
2012). Mutating the Sp binding sites on Atp1a1, Atp1a3, and
Atp1b1 promoters led to a significant decrease in their promoter
activity. Silencing Sp1, Sp3, or Sp4 significantly decreased the
mRNA levels of α1-, α3-, and β1-subunit, while overexpressing
Sp1, Sp3, and Sp4 increased their transcription (Johar et al.,
2012). Sp1 also binds to two Sp binding sites located near its
TATA box on rat Atp1b2 promoter and enhanced the expression
of β2-subunit. In addition, the functional Sp-binding site on
Atp1a1 promoter is well conserved in rat brain, kidney and liver
(Suzuki-Yagawa et al., 1992; Kobayashi et al., 1997; Nemoto et al.,
1997), indicating that it might contribute to the constitutional
expression of α1-subunit. The Sp binding sites are also required
for the regulation of Na,K-ATPase transcription in response
to extracellular stimuli. For example, hyperoxia selectively up-
regulated β1-subunit transcription in MDCK cells (Wendt et al.,
1998). Hyperoxia increased the binding of Sp1 and Sp3 to the
Atp1b1 promoter and deletion of a GC rich element resulted in
loss of both basal and hyperoxia-activated transcription (Wendt
et al., 2000). Sp might also augment transcriptional activation of
Na,K-ATPase through other transcription factors. For example,
Sp1 significantly enhanced MR and GR expression (Kolla et al.,
1999) and elevated MR and GR might synergize with Sp1 to
upregulate Na,K-ATPase transcription.
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Snail
Snail1 is the first identified member of the Snail family, which
belongs to the zinc-finger transcription factors and has three
members in vertebrates: Snail1, Snail2, and Snail3. The Snail
family has a highly conserved C-terminal region, which is the
DBD containing four to six zinc fingers; and a divergent N-
terminal region, which contains a SNAG (Snail/Gfi) domain
and recruits the transcription repressor complex (such as
sin3A/HDAC). The Snail family functions as a transcriptional
repressor by binding to the E-box (CAGGTG) on the promoter
regions of target genes which are important for embryonic
development as well as tumor progression (Nieto, 2002). Four E-
boxes and a non-canonical E-box are present on the promoter
region of the ATP1B1 gene. Snail1 binds to the non-canonical
E-box located at position −71 to −66 bp and selectively
repressed the expression of β1-subunit without affecting the
α1-subunit level (Espineda et al., 2004). Overexpression of
Snail1 repressed ATP1B1 promoter activity in a dose dependent
manner and markedly reduced the level of β1-subunit in MCF7
and MDCK cells. Knock-down of Snail by RNA interference
increased the abundance of β1-subunit mRNA (Espineda et al.,
2004).
Activating Transcription Factor 1
(ATF-1)/cAMP Response Element Binding
Protein (CREB) Family
ATF/CREB belongs to the basic leucine zipper factor (bZIP)
family, which bind to DNA as dimers and function as
activators. The ATF/CREB family is composed of different
ATFs, CREB, CREM (cAMP response element modulator) and
related proteins. This family contains an N-terminal DBD and
a C-terminal bZIP domain that binds other bZIP transcription
factors to form homo- and heterodimers. Both ATF and CREB
bind to the cAMP response element (CRE: GTGACGT A/C
A/G). Phosphorylation of ATF-1 and CREB by multiple kinases
enhances the binding to CRE and activates the transcription
of target genes which play an important role in cell survival
and cell growth (Hai and Hartman, 2001). Dibutyryl cAMP
(db-cAMP), a cell-permeable cAMP analog that activates cAMP
dependent protein kinase (PKA) and phosphorylates the CREB
family, induced the mRNA of α1-subunit but not β1-subunit
(Dagenais et al., 2001). The rat Atp1a1 promoter has an
asymmetrical ATF/CRE site at position−70 to−66 bp. The ATF-
1/CREB heterodimer bound to this site and induced constitutive
expression of αl-subunit. Blocking the binding of ATF-1/CREB
to the CRE site reduced α1-subunit transcription (Kobayashi
and Kawakami, 1995). Phosphorylated ATF-1 increased rat α1-
subunit transcription and dephosphorylation of the ATF-1/CREB
heterodimer by alkaline phosphatase reduced its binding to
the CRE site on rat Atp1a1 gene (Kobayashi et al., 1997).
In addition, human ATP1A4 promoter region has consensus
CRE sites. db-cAMP and ectopic expression of CREMtau, a
testis specific splice variant of CREM activated the ATP1A4
promoter activity. This activation required the CRE site located
at −263 bp relative to the transcription initiation site (Rodova
et al., 2006).
Zinc Finger E-Box Binding Homeobox 1
(ZEB1)
The ZEB family has two members in vertebrates: ZEB1 (also
known as Areb6) and ZEB2. They contain five major domains:
two zinc-finger clusters separated by a central homeodomain, a
Smad interacting domain (SID) and a CtBP interacting domain
(CID). Each zinc finger cluster contains 3 or 4 zinc fingers and
is responsible for DNA binding. ZEB binds to E-boxes (CACCT
and CACCTG) on the promoter of target genes and recruits co-
activators (PCAF or p300), thus activating gene transcription
(Vandewalle et al., 2009). The rat Atp1a1 promoter has a
consensus Areb6 (ZEB1) binding sequence and Areb6 (ZEB1)
had been shown to activate gene transcription in a cell-specific
manner (Watanabe et al., 1993). High-fat diet also induced
the binding of ZEB to rat Atp1α1 promoter and increased
the mRNA and protein level of α1-subunit in nuclear extracts
from gastrocnemius muscle (Galuska et al., 2009). Moreover, C-
peptide increased the binding of ZEB to rat Atp1α1 promoter
region. Partial silencing of ZEB markedly reduced the effect of C-
peptide on the increase in α1-subunit expression (Galuska et al.,
2011). In addition, ZEB binding sites were also found on FXYD1
promoter at positions −270 to −295 bp and −329 to −354 bp
(Galuska et al., 2009).
CCAAT Box Binding Transcription Factors
(CBFs)
CCAAT box is one of the most common elements in eukaryotic
promoters, which is often found between -60 to -100 bp relative
to the transcription initiation site. Several transcription factors
have been reported to bind to the CCAAT box, including NF-Y,
NF-1, and CCAAT/enhancer-binding protein (C/EBP) isoforms
(CEBP-α, CEBP-β, CEBP-γ, CEBP-δ, and CEBP-ε), which are
essential for optimal transcriptional activation of target genes
(Mantovani, 1998). CCAAT boxes have been found in Atp1a2,
Atp1a3, and Atp1b1 promoter regions (Pathak et al., 1990;
Malyshev et al., 1991; Benfante et al., 2005; Deng et al., 2013).
The CCAAT box (−61 to −64 bp) on human ATP1A3 promoter
is well conserved between rat and human and NF-YB had
been shown to bind to this CCAAT box. The presence of the
CCAAT box significantly increased ATP1A3 promoter activity in
both neuron and non-neuron cell lines, while mutations in the
CCAAT box reduced the promoter activity (Benfante et al., 2005).
In addition, the CCAAT/enhancer binding protein beta (Cebpb)
might be involved in regulating β1-subunit expression in human
luminal epithelial cells. The active isoform of Cebpb significantly
increased Atp1b1 promoter activity, but the truncated isoform of






Transforming growth factor-β (TGF-β) is a secreted protein
that regulates numerous physiological processes, including cell
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differentiation, proliferation, development and survival. TGF-β
has three isoforms in mammals: TGF-β1, TGF-β2, and TGF-
β3, which are encoded by different genes. Aberrant TGF-β
signaling has been linked to cancer initiation, invasion and
metastasis (Lamouille et al., 2014). TGF-β treatment reduced
mRNA and protein levels of Na,K-ATPase α- and β-subunits
in primary cultures of renal proximal tubule cells (Tang et al.,
1995). However, TGF-β1 seems to regulate Na,K-ATPase subunit
expression in a cell type specific manner. Some studies showed
that TGF-β1 reduced β1-subunit as well as α1-, α2-, and α3-
subunit mRNA levels in young FRTL-5 rat thyroid cells (Pekary
et al., 1997). Studies from our group found that although TGF-
β1 decreased the surface levels of β1-subunit in kidney cells,
this seemed to occur at the post-translational level since no
significant changes in mRNA levels were observed between
control and TGF-β1-treated cells (Rajasekaran et al., 2010). TGF-
β1 also prevented the increase in α1-subunit mRNA induced by
steroid hormones (Husted et al., 2000). Nevertheless, TGF-β2
selectively decreased the transcription of β1-subunit in ARPE-19
cells, a human retinal pigmented epithelial cell line, involving two
transcription factors: hypoxia inducible factor (HIF) and Smad3
(Mony et al., 2013). HIF belongs to the basic helix-loop-helix
(bHLH) superfamily and is a heterodimer composed of a hypoxia
induced HIF-α subunit and a constitutively expressed HIF-1β
subunit. Three HIF-α subunits have been identified so far: HIF-
1α, HIF-2α, and HIF-3α. HIF-1α contains three major domains:
a N-terminal domain, which is a DBD containing a bHLH; an
oxygen-dependent degradation domain (ODDD) that mediates
oxygen-regulated protein stability and a C-terminal domain,
which recruits transcriptional coactivators such as CBP/p300 to
activate gene transcription. The HIF complex associates with
hypoxia response elements (HREs) in the regulatory regions of
target genes and binds the transcriptional coactivators to induce
gene expression. Besides hypoxia, HIF-1 is also regulated in
an oxygen-independent manner (Ke and Costa, 2006). TGF-β2
increased HIF-1α expression in ARPE-19 cells and blocking the
binding of HIF-1α to HREs with echinomycin prevented the
TGF-β2-induced decrease of the β1-subunit (Mony et al., 2013).
Since HIF-1α generally functions as a transcriptional activator,
this observation raised the possibility that other transcription
repressors may antagonize the function of HIF-1α in the
regulation of Na,K-ATPase expression. The ATP1B1 promoter
region also contains a SBD in close proximity to a putative
HRE. Smads are transcription modulators usually activated by
TGF-β signaling that can inhibit gene expression by preventing
the action of transcriptional activators (Massague et al., 2005).
Studies in ARPE19 cells indeed support the idea that both
Smad3 and HIF-1α cooperated in regulating the expression of
β1-subunit expression by TGF-β2 (Mony et al., 2013).
Fibroblast Growth Factor
Fibroblast growth factors (FGFs) control a wide range
of biological functions and regulate cellular proliferation,
survival, migration, and differentiation. FGFs are a family of
glyocoproteins that are generally sequestered by the extracellular
matrix and cell surface heparan sulfate proteoglycans. Activation
of FGF signaling occurs upon release of the factor and binding
to one of the four highly conserved FGF receptors, FGR1, FGR2,
FGR3, and FGR4 (Turner and Grose, 2010). Incubation of cells
in serum rapidly increased α1- and β1-subunit mRNA levels
in VSMC and rat liver cells and induced Atp1a1 and Atp1b1
promoter activity, suggesting that serum regulates Na,K-ATPase
gene expression at the transcriptional level (Kirtane et al., 1994;
Nemoto et al., 1997). Serum differentially regulated α1- and
β1-subunit mRNA induction and activation of PKC and tyrosine
kinase activity was required for up-regulation of α1-subunit
mRNA but not for β1-subunit. Further studies revealed that FGF
treatment stimulated Atp1a1 and Atp1b1 promoter activities,
similar to the observation in serum treated VSMC (Nemoto
et al., 1997). Furthermore, keratinocyte growth factor (KGF), a
member of the FGF family and a polypeptide mitogen secreted by
fibroblasts and endothelial cells that acts primarily on epithelial
cells, increased the abundance of α1-subunit, but not β1-subunit
mRNA in alveolar type II cells (Borok et al., 1998).
PROSTAGLANDIN AND Na,K-ATPase
TRANSCRIPTION
Prostaglandin E1 (PGE1) is a member of the prostaglandin
family, which are lipidmediators produced from arachidonic acid
by cyclooxygenase and prostaglandin synthases. Prostaglandins
exert their effects by activating G protein-coupled receptors
and four PGE receptors have been reported: EP1 (E prostanoid
receptor 1), EP2, EP3, and EP4 (Sugimoto and Narumiya,
2007). Prostaglandins are important regulators of ion transport
in the kidney (Bonvalet et al., 1987) and PGE1 increased the
transcription of α- and β-subunit of Na,K-ATPase in MDCK
cells (Taub et al., 1992, 2004; Matlhagela and Taub, 2006).
The increase in the transcription of β1-subunit induced by
PGE1 was mediated by EP1 and EP2 receptors and PGE
receptor antagonists inhibited the promoter activity of human
ATP1B1 induced by PGE1 (Matlhagela and Taub, 2006). Three
prostaglandin response elements (PGRE) have been identified
within the human ATP1B1 promoter, which are located at
position −445 to −438 bp (PGRE1: TGACCTTC); −226 to
−216 bp (PGRE2: GTCCCTCA); and −92 to −100 bp (PGRE3:
AGTCCCTGC; Matlhagela et al., 2005; Matlhagela and Taub,
2006) and PGRE1 is well conserved among species (Matlhagela
and Taub, 2006). The PGRE sequence is similar to the consensus
CRE, and CREB had been shown to bind to these sequences
indicating that PGREs might be cAMP response elements. The
binding affinity of CREB to three PGREs was varied with PGRE3
> PGRE1 > PGRE2 (Matlhagela et al., 2005). Sp1, Sp3 as well
as CREB all bound to PGRE (Matlhagela and Taub, 2006) and
the increase in transcription of β1-subunit was mediated through
CREB binding to PGRE1 and PGRE3 as well as Sp1 binding to an
adjacent Sp1 site (Matlhagela et al., 2005; Matlhagela and Taub,
2006). Mutations in PGRE3 or the GC box (−118 to −112 bp)
immediately downstream of PGRE3 failed tomediate the increase
in ATP1B1 promoter activity induced by PGE1 (Matlhagela and
Taub, 2006). Besides PGE1, PGE2 and PGF2α also have been
shown to induce ATP1B1 promoter activity in primary renal
proximal tubule (RPT) cells (Herman et al., 2010).
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Na,K-ATPase ACTIVITY AND
TRANSCRIPTIONAL REGULATION
Chronic inhibition of Na,K-ATPase activity by ouabain leads
to an increase in the abundance of Na,K-ATPase. For example,
ouabain increased the mRNA levels of α1- and β1-subunit in
cultured rat astrocytes (Hosoi et al., 1997; Muto et al., 2000),
which was abolished by actinomycin D, a transcription inhibitor
acting by interfering with mRNA synthesis (Muto et al., 2000).
Ouabain also regulated the transcription of α3- and β1-subunit
in cultured neonatal rat cardiac myocytes. Ouabain augmented
the Atp1b1 promoter activity and the effect of ouabain on
the regulation of Na,K-ATPase subunits was dependent on
extracellular Ca2+ and calmodulin (Kometiani et al., 2000). The
inhibition of Na,K-ATPase activity by ouabain can be mimicked
by incubating cells in a lowK+ environment and low extracellular
K+ increased α1- and β1-subunit mRNA levels in rat cardiac
myocytes (Qin et al., 1994; Zhuang et al., 2000; Wang et al.,
2007a). Sp and CREB family transcription factors were required
for the up-regulation of Na,K-ATPase subunits induced by low
K+. Rat Atp1a1 promoter region has a CRE/ATF site (at −70
to −63 bp) and a GC box motif (at −57 to −48 bp). Mutations
in the CRE/ATF site or GC box substantially reduced low
K+-mediated Atp1a1 promoter activity. Low K+ increased the
expression of Sp1, Sp3 and CREB-1 and enhanced the binding
of these transcription factors to the GC box and, to a lesser
extent, to the CRE/ATF site on rat Atp1a1 promoter (Wang
et al., 2007b). The sequences between -102 to +151 bp on rat
Atp1b1 were required for low K+-induced trans-activation of
reporter gene expression (Qin et al., 1994). Low K+ enhanced
the binding of Sp1 and Sp3 to GC box elements on the Atp1b1
promoter (Zhuang et al., 2000). Mutations in potential GC box
sequences decreased basal and low K+-mediated up-regulation
of β1-subunit transcription in neonatal rat cardiac myocytes
(Zhuang et al., 2000). Inhibiting the binding of Sp1 and Sp3 to GC
boxes by mithramycin, which has high affinity for GC-rich DNA
sequences (Matlhagela et al., 2005), blocked low K+-mediated
up-regulation of Atp1a1 and Atp1b1 promoter activity. Multiple
cellular signaling pathways were involved in this low K+-induced
increase in the transcription of α1- and β1-subunits. Protein
kinase A (PKA), ERK1/2, and histone deacetylase (HDAC) were
required for up-regulation of α1-subunit transcription, whereas
the transcription of β1-subunit was dependent on protein kinase
C (PKC), c-Jun-N-terminal kinase (JNK) and p38 mitogen-
activated protein kinase (MAPK; Wang et al., 2007a). However,
it is important to point out that inhibition of Na,K-ATPase and
therefore an increase in intracellular sodium regulates Na,K-
ATPase on multiple levels including transcription, transport,
endocytosis and degradation (Vinciguerra et al., 2003, 2004;
Wang et al., 2014).
NEURONAL ACTIVITY AND Na,K-ATPase
TRANSCRIPTIONAL REGULATION
α1-, α3-, and β1-subunits are abundantly expressed in most
neurons in the central nervous system and neuronal activity
modulates the transcription of Na,K-ATPase subunits.
Depolarization by KCl increased the promoter activities as
well as the mRNA levels of α1-, α3- and β1-subunits; however,
impulse blockade induced by tetrodotoxin (TTX), a voltage-
dependent Na+ channel blocker, significantly reduced α1-, α3-,
and β1-subunit transcripts in murine neurons (Johar et al., 2012,
2014). At least two transcription factors were involved in this
activity-dependent transcriptional regulation in neurons, nuclear
respiratory factor 1 (NRF1) and the Sp family (Johar et al., 2012,
2014).
NRF1 is a transcription factor which was first identified
as an activator of cytochrome C (Evans and Scarpulla, 1989).
NRF1 increases the expression of nuclear genes required for
mitochondrial biogenesis and function, but also binds to the
promoter region of target genes which control cell cycle, cell
growth, cell adhesion, migration, and tumor invasion (Okoh
et al., 2011). Increased NRF1 levels have been observed in
hepatoma, thyroid oncocytoma and breast cancers (Dong et al.,
2002; Savagner et al., 2003; Okoh et al., 2011). The consensus
NRF1 binding site is (T/C)GCGCA(C/T)GCGC(A/G), which
is a GC-rich element. In addition, NRF1 binds to sequences
with an invariant GCA core flanked by GC-rich regions, which
can be found in 5′ flanking regions of Atp1a1, Atp1a3, and
Atp1b1 genes. It has been reported that NRF1 binds to the
promoter regions of Atp1a1 and Atp1b1 in murine neurons
at binding sites that are conserved among mice, rats and
humans. Mutations in the NRF1 binding sites significantly
decreased Atp1b1 promoter activity, but increased Atp1a1
promoter activity, which indicates that NRF1 differentially
regulates Na,K-ATPase subunits. Indeed, silencing of NRF1
significantly decreased β1-subunit transcript but increased the
mRNA level of α1-subunit and overexpression of NRF1 increased
the mRNA level of the β1-subunit but decreased the α1-subunit
transcript. NRF1 itself is regulated by neuronal activity (Yang
et al., 2006). Depolarization by KCl increased NRF1 expression,
and TTX reduced the NRF1 expression (Johar et al., 2012)
and knockdown of NRF1 with small interference RNA blocked
the up-regulation of the β1-subunit and down-regulation of
the α1-subunit induced by KCl, whereas overexpression of
NRF1 rescued the down-regulation of the β1-subunit and up-
regulation of the α1-subunit by TTX. The inverse regulation
of Na,K-ATPase α1- and β1-subunit by NRF1 in response to
KCl and TTX points to additional transcription factors and
an intricate network regulating Na,K-ATPase expression by
neuronal activity.
Sp transcription factors are regulated by neuronal activity and
depolarization by KCl increased Sp1 and Sp4 expression, while
TTX reduced the expression of Sp1 and Sp4 (Johar et al., 2014).
Sp1, Sp3, and Sp4 bound to the promoter regions of Atp1a1,
Atp1a3, and Atp1b1 in murine neurons, and Sp4 showed the
highest binding affinity. Mutations in the Sp binding sites of
Atp1a1, Atp1a3, and Atp1b1 promoters significantly decreased
the promoter activity. Silencing Sp1, Sp3, and Sp4 decreased
α1-, α3-, and β1-subunit mRNA levels; while overexpression of
Sp1, Sp3, and Sp4 increased α1-, α3-, and β1-subunit transcripts.
Silencing Sp1 or Sp4 also blocked the KCl-induced up-regulation
of Na,K-ATPase subunits and overexpression of Sp1, Sp3, or Sp4
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rescued the down-regulation of Na,K-ATPase subunits by TTX
(Johar et al., 2014).
EPIGENETIC MECHANISMS IN THE
REGULATION OF Na,K-ATPase
TRANSCRIPTION
DNA methylation is an important epigenetic mechanism in the
regulation of gene expression.Methylation generally occurs at the
cytosine bases of CpG sequences throughout the entire genome,
with the exception of CpG islands usually found in gene promoter
regions (Cedar and Bergman, 2009). Methylation patterns often
depend on tissue type and developmental stage, correlating
with transcriptional activity. Aberrant DNAmethylation patterns
have been linked to altered gene expression in various genetic
diseases and tumors (Bird, 2002). Higher methylated CpGs were
found in the first exon of Atp1a3, which correlated with the
lower expression of this gene in pig liver (Henriksen et al.,
2013). Manganese exposure led to sustained Atp1a3 promoter
hypermethylation and downregulation of its transcript level
in mice (Wang et al., 2013). CpG islands are also found in
ATP1B1 and Atp1b2 promoter regions (Alvarez de la Rosa et al.,
2002; Selvakumar et al., 2014), which are conserved between
human and mice and remain unmethylated (Alvarez de la Rosa
et al., 2002). However, ATP1B1 promoter is hypermethylated
in tumor samples of clear cell renal cell carcinoma, which
showed reduced β1-subunit levels (Selvakumar et al., 2014).
Knock-down of the tumor suppressor gene von Hippel-Lindau
(VHL) enhanced ATP1B1 promoter methylation and decreased
β1-subunit expression, while inhibition of methyltransferase by
5-Aza-2′-deoxycytidine rescued β1-subunit mRNA expression in
VHL-knockdown cells (Selvakumar et al., 2014).
Methylation is also involved in transcriptional regulation
and differential distribution of FXYD1. The FXYD1 promoter
contains methylated cytosines and a predicted CpG island. 5′-
aza-cytidine markedly increased FXYD1 mRNA levels. Mouse
heart showed lower methylation in fxyd1 promoter and higher
fxyd1 expression; while brain had a higher methylation of
the fxyd1 promoter and lower fxyd1 expression (Deng et al.,
2007). In brain, the fxyd1 mRNA level is lower in the frontal
cortex than in cerebellum, which correlates with the more
frequent promoter methylation found in frontal cortex (Banine
et al., 2011). The fxyd1 promoter is a target of the Methyl
CpG binding protein 2 (MeCP2), a common transcriptional
modulator. MeCP2 directly bound to methylated CpG in the
fxyd1 promoter and repressed fxyd1 transcription (Deng et al.,
2007). On the other hand, activating histones, such as histone
3 acetylated at lysines 9 and 14 (H3K9/14ac) and histone
3 methylated at lysine 4 (H3K4me3), disassociated with the
fxyd1 promoter to augment the inhibitory effect (Banine et al.,
2011).
CONCLUSIONS
The expression of Na,K-ATPase is transcriptionally regulated
by hormones, growth factors, lipid mediators and other
extracellular stimuli through mediating transcription factor
binding to promoter regions of Na,K-ATPase subunits. Many
regulators of Na,K-ATPase are involved in the response to
demands of cellular activity and ion homeostasis. Together
with the spatial and temporal regulation of Na,K-ATPase
subunits and their individual isoforms, this allows for a complex
and controlled regulation of Na,K-ATPase in response to
physiological demands in a tissue-specific manner. Interestingly,
various recently identified transcriptional regulators of Na,K-
ATPase are transcription factors that are also activated during
development, in stem cells and during epithelial-mesenchymal
transition (EMT). EMT is a switch in which epithelial cells
undergo a shift from a well-differentiated polarized epithelial
phenotype to a fibroblastic, mesenchymal phenotype and is a
natural developmental process in tissue and organ formation.
EMT can also be activated during wound healing, in tissue
fibrosis, and is a major factor in cancer developing into a
malignant disease (Kalluri andWeinberg, 2009). Vice versa, EMT
activated transcription factors regulate the expression of Na,K-
ATPase. For example, TGF-β and FGF up-regulate the expression
of ZEB1, ZEB2, and Snail; steroid hormones, IGF-1 and PGE2
also induce ZEB1 and ZEB2. And ZEB1 and Snail1 regulate the
transcription of Na,K-ATPase. Most recently, we identified the
β1-subunit as a target of the Sonic hedgehog (Shh) signaling
pathway (Lee et al., 2015). Shh is a critical morphogen involved
in patterning of the early embryo and organogenesis, including
the neural tube and limb system. The correlation between these
signaling pathways and the transcriptional regulation of Na,K-
ATPase is intriguing as elucidating the cross-regulation network
among these factors may help in our understanding of the role of
Na,K-ATPase with its pump-dependent and pump-independent
functions in normal development, stem cell biology, and disease.
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